SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Board Appointment

22 Jul 2024 07:00

RNS Number : 1110X
Bowleven plc
22 July 2024
 

 

 

 

22nd July 2024

 

 

Bowleven plc ('Bowleven')

Board Appointment

Bowleven plc ("Bowleven" or the "Company") announces that Mark Vermeulen has been appointed as a Non-Executive Director with immediate effect.

 

Mark is a partner, Chief Investment Officer and fund manager at Ophorst van Marwijk Kooy Vermogensbeheer NV ("OVMK"), a value-oriented investment firm focussed on both mid and small-cap equities in the UK, Hong Kong and Europe, and high-yield bonds. He has spent the last 15 years managing a range of international bond and value funds for OVMK, with significant exposure to oil & gas related investments. He has previously worked at Dresdner Bank as an analyst across a number of international equity funds. Mark is a CFA Charterholder.

 

Eli Chahin, CEO of Bowleven, commented:

"We are delighted to welcome Mark to the Board. Mark brings his extensive financial, corporate and governance experience. His appointment is complementary to the existing Board as we together continue to focus on the overall strategy of establishing Etinde as the foremost project development in Cameroon."

 

Further information in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies (the "AIM Rules") is set out at the end of this announcement.

 

ENQUIRIES

 

For further information, please contact:

 

Bowleven plc

 

Eli Chahin, Chief Executive

+ 44 20 3327 0150

 

Camarco (Financial PR)

Owen Roberts

+ 44 20 3757 4980

Hugo Liddy

Shore Capital (NOMAD and Broker)

Daniel Bush

Rachel Goldstein

+ 44 20 7408 4090

 

 

 

 

Appendix - Rule 17 and Schedule Two (g) disclosures

 

Save for the information set out above and below, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules in respect of the appointment of Markus (Mark) Franciscus Antonius Vermeulen, aged 41. Mark does not hold a direct interest in the Company's ordinary share capital; however, OVMK, of which Mark is a partner and fund manager, manages an interest in 14,779,175 shares on behalf of its clients, representing 0.78% of the Company's total issued ordinary share capital (excluding shares held in treasury).

 

 

Current Directorships/Partnerships

Ophorst van Marwijk Kooy Vermogensbeheer NV

Podere Fignano SNC

 

Past Directorships/Partnerships (within 5 years)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOARLMTTMTBBBLI
Date   Source Headline
8th Dec 202111:53 amRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20217:00 amRNSPosting of Annual Report and Accounts 2021
10th Nov 202111:05 amRNSSecond Price Monitoring Extn
10th Nov 202111:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSFull Year Results
9th Nov 20218:55 amRNSBlock Admission Six Monthly Return
20th Aug 20214:41 pmRNSSecond Price Monitoring Extn
20th Aug 20214:36 pmRNSPrice Monitoring Extension
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn
20th Aug 20212:00 pmRNSPrice Monitoring Extension
20th Aug 202111:05 amRNSSecond Price Monitoring Extn
20th Aug 202111:00 amRNSPrice Monitoring Extension
20th Aug 20219:05 amRNSSecond Price Monitoring Extn
20th Aug 20219:00 amRNSPrice Monitoring Extension
24th May 20212:06 pmRNSSecond Price Monitoring Extn
24th May 20212:00 pmRNSPrice Monitoring Extension
14th May 202111:05 amRNSSecond Price Monitoring Extn
14th May 202111:00 amRNSPrice Monitoring Extension
13th May 202111:06 amRNSSecond Price Monitoring Extn
13th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:15 amRNSBlock Admission Six Monthly Return
30th Mar 20212:05 pmRNSSecond Price Monitoring Extn
30th Mar 20212:01 pmRNSPrice Monitoring Extension
30th Mar 20219:05 amRNSSecond Price Monitoring Extn
30th Mar 20219:00 amRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSInterim Results
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
3rd Mar 20217:00 amRNSHolding(s) in Company
12th Feb 202111:06 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
27th Jan 20215:50 pmRNSTR-1: Notification of major holdings
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSEtinde Exploitation Authorisation Agreement
11th Jan 20217:00 amRNSAppointment of Chairman
31st Dec 202012:35 pmRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:36 pmRNSPrice Monitoring Extension
17th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 202011:06 amRNSResult of Annual General Meeting
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
24th Nov 20204:40 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.